Gene therapy: Recent advances and applications in dermatology

Journal of Cutaneous Medicine and Surgery

Volumn 1, Issue 2, 1996, Pages 109-118

  Hope, Michael J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Inex Pharmaceuticals   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE;

ARTICLE; CANCER IMMUNOTHERAPY; DERMATOLOGY; EPIDERMIS CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; KERATINOCYTE; PRIORITY JOURNAL; SKIN; SKIN DISEASE; STEM CELL;

EID: 0030316973     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/120347549600100210     Document Type: Article

References (24)

1. - SCID: initial trial results after 4 years. Science 1995; 270:475-480.
2. Friedmann T. Gene therapy - a new kind of medicine. Trends Biotechnol 1993; 11:56-159.
3. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270:404-410.
4. Nabel GJ, Felgner PL. Direct gene transfer for immunotherapy and immunization. Trends Biotechnol 1993; 11:211-215.
5. Friedmann T. Human gene therapy - an immature genie, but certainly out of the bottle. Nature Med 1996; 2:144-147.
6. Zier KS, Gansbacher B. The impact of gene therapy on T cell function in cancer. Hum Gene Ther 1995; 6:1259-1264.
7. Pardoll DM. New strategies for enhancing the immunogenicity of tumours. Curr Opin Immunol 1993; 5:719-725.
8. Rosenberg SA. Immunotherapy and gene therapy of cancer. Cancer Res 1991; 51:5074S-5079S.
9. Ettinghausen SE, Rosenberg SA. Immunotherapy and gene therapy of cancer (Review). Adv Surg 1995; 28:223-254.
10. Spooner RA, Deonarain MP, Epenetos AA. DNA vaccination for cancer treatment. Gene Ther 1995; 2:173-180.
11. Nabel GJ, Nabel EG, Yang ZY, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 1993;90:11307-11311.
12. Plautz GE, Yang ZY, Wu BY, et al. Immunotherapy of malignancy by in vivo gene transfer into tumours. Proc Natl Acad Sci U S A 1993; 90:4645-4649.
13. Nabel EG, Yang Z, Muller D, et al. Safety and toxicity of catheter gene delivery to the pulmonary vasculature in a patient with metastatic melanoma. Hum Gene Ther 1994; 5:1089-1094.
14. Tiberghien P. Use of suicide genes in gene therapy. J Leukocyte Biol 1994; 56:203-209.
15. Mullen CA. Metabolic suicide genes in gene therapy. Pharmacol Ther 1994; 63:199-207.
16. Riddell SR, Elliott M, Lewinsohn DA, et al. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nature Med 1996; 2:216-223.
17. Morgan RA, Baler-Bitterlich G, Ragheb JA, et al. Further evaluation of soluble CD4 as an anti-HIV type 1 gene therapy: demonstration of protection of primary human peripheral blood lymphocytes from infection by HIV type 1. AIDS Res Hum Retroviruses 1994; 10:1507-1515.
18. Lisziewicz J, Sun D, Lisziewicz A, Gallo RC. Antitat gene therapy: a candidate for late-stage AIDS patients. Gene Ther 1995; 2:218-222.
19. Lisziewicz J, Sun D, Trapnell B, et al. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy. J Virol 1995; 69:206-212.
20. Chang HK, Gendelman R, Lisziewicz J, et al. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1. Gene Ther 1994; 1:208-216.
21. Wolff JA, Ludtke JJ, Acsadi G, et al. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Molec Genet 1992; 1:363-369.
22. Wolff JA, Dowry ME, Jiao S, et al. Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle. J Cell Science 1992; 103:1249-1259.
23. Whalen RG, Davis HL. DNA-mediated immunization and the energetic immune response to hepatitis B surface antigen. Clin Immunol Immunopathol 1995; 75:1-12.
24. Davis HL, Michel M, Mancini M, et al. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994; 12:1503-1509.